Table 4

Multivariate analysis of prognostic factors in NSCLC

Prognostic factorsβPRelative hazard (95% confidence interval)
a. Age0.0250.0711.025 (0.998–1.052)
Sex (male/female)−0.5870.0870.570 (0.301–1.036)
PS (0/1/2)0.2810.3271.324 (0.756–2.319)
Histologic type (nonadenocarcinoma/adenocarcinoma)−0.0380.2380.963 (0.905–1.025)
p-stage (I, II, IIIa)0.727<0.0012.068 (1.594–2.682)
CD34-IMVD (lower/higher)0.4340.0701.543 (0.965–2.466)
b. Age0.0240.0771.024 (0.998–1.052)
Sex (male/female)−0.4460.1270.640 (0.361–1.136)
PS (0/1/2)0.2790.3301.321 (0.755–2.313)
Histologic type (nonadenocarcinoma/adenocarcinoma)−0.0420.1920.959 (0.900–1.021)
p-stage (I, II, IIIa)0.628<0.0011.874 (1.464–2.399)
CD105-IMVD (lower/higher)0.5200.0291.662 (1.056–2.679)